191 related articles for article (PubMed ID: 10825461)
1. Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.
Riby JE; Chang GH; Firestone GL; Bjeldanes LF
Biochem Pharmacol; 2000 Jul; 60(2):167-77. PubMed ID: 10825461
[TBL] [Abstract][Full Text] [Related]
2. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol.
Chang YC; Riby J; Chang GH; Peng BC; Firestone G; Bjeldanes LF
Biochem Pharmacol; 1999 Sep; 58(5):825-34. PubMed ID: 10449193
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
Leong H; Firestone GL; Bjeldanes LF
Carcinogenesis; 2001 Nov; 22(11):1809-17. PubMed ID: 11698343
[TBL] [Abstract][Full Text] [Related]
4. Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways.
Leong H; Riby JE; Firestone GL; Bjeldanes LF
Mol Endocrinol; 2004 Feb; 18(2):291-302. PubMed ID: 14645498
[TBL] [Abstract][Full Text] [Related]
5. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway.
Riby JE; Feng C; Chang YC; Schaldach CM; Firestone GL; Bjeldanes LF
Biochemistry; 2000 Feb; 39(5):910-8. PubMed ID: 10653634
[TBL] [Abstract][Full Text] [Related]
6. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
7. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
Hong C; Kim HA; Firestone GL; Bjeldanes LF
Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells.
Hong C; Firestone GL; Bjeldanes LF
Biochem Pharmacol; 2002 Mar; 63(6):1085-97. PubMed ID: 11931841
[TBL] [Abstract][Full Text] [Related]
9. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
Le HT; Schaldach CM; Firestone GL; Bjeldanes LF
J Biol Chem; 2003 Jun; 278(23):21136-45. PubMed ID: 12665522
[TBL] [Abstract][Full Text] [Related]
10. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
Liu H; Wormke M; Safe SH; Bjeldanes LF
J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
[TBL] [Abstract][Full Text] [Related]
11. Activation and potentiation of interferon-gamma signaling by 3,3'-diindolylmethane in MCF-7 breast cancer cells.
Riby JE; Xue L; Chatterji U; Bjeldanes EL; Firestone GL; Bjeldanes LF
Mol Pharmacol; 2006 Feb; 69(2):430-9. PubMed ID: 16267208
[TBL] [Abstract][Full Text] [Related]
12. Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines.
Mulvey L; Chandrasekaran A; Liu K; Lombardi S; Wang XP; Auborn KJ; Goodwin L
Mol Med; 2007; 13(1-2):69-78. PubMed ID: 17515958
[TBL] [Abstract][Full Text] [Related]
13. Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.
Marques M; Laflamme L; Benassou I; Cissokho C; Guillemette B; Gaudreau L
BMC Cancer; 2014 Jul; 14():524. PubMed ID: 25048790
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha as a target for indole-3-carbinol.
Wang TT; Milner MJ; Milner JA; Kim YS
J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor.
Al-Zaubai N; Johnstone CN; Leong MM; Li J; Rizzacasa M; Stewart AG
J Pharmacol Exp Ther; 2014 Oct; 351(1):172-80. PubMed ID: 25077525
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
Chen I; McDougal A; Wang F; Safe S
Carcinogenesis; 1998 Sep; 19(9):1631-9. PubMed ID: 9771935
[TBL] [Abstract][Full Text] [Related]
17. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
18. Bivalent ligands as probes of estrogen receptor action.
Bergmann KE; Wooge CH; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):139-52. PubMed ID: 8031710
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
